Lobbying client

TAKEDA PHARMACEUTICALS U.S.A., INC.

pharmaceutical company

Filings
16
Filed by
1
Reported in-house
—
Reported by firms
$690,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2013 to 2016

Filings

16 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2016
THORN RUN PARTNERS $20,000 reported
2nd Quarter - Report
2nd Quarter 2016
THORN RUN PARTNERS $50,000 reported
1st Quarter - Report
1st Quarter 2016
THORN RUN PARTNERS $50,000 reported
4th Quarter - Report
4th Quarter 2015
THORN RUN PARTNERS $50,000 reported
3rd Quarter - Report
3rd Quarter 2015
THORN RUN PARTNERS $50,000 reported
2nd Quarter - Report
2nd Quarter 2015
THORN RUN PARTNERS $50,000 reported
1st Quarter - Report
1st Quarter 2015
THORN RUN PARTNERS $50,000 reported
4th Quarter - Report
4th Quarter 2014
THORN RUN PARTNERS $50,000 reported
3rd Quarter - Report
3rd Quarter 2014
THORN RUN PARTNERS $50,000 reported
2nd Quarter - Report
2nd Quarter 2014
THORN RUN PARTNERS $50,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THORN RUN PARTNERS 15 $690,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medicare/Medicaid MMM 16
Health Issues HCR 5
Insurance INS 4

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 1509 114th 6
H.R. 2404 114th 6
H.R. 2415 113th 4
S. 1184 113th 4

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.